Manufacturer Sterling Pharma Solutions is investing £6m into its UK pilot plant facility to enhance its scale-up and small to midscale-commercial API manufacturing capabilities.
The pharma company is investing £6m into its UK pilot facility – image courtesy of Sterling Pharma Solutions. The expansion will increase the pilot plant’s capacity by 33% and enhance the site’s production capabilities and flexibility for small to mid-scale batch production. The investment will add three new reactor trains at…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
